Compare ATRC & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | ECVT |
|---|---|---|
| Founded | 2000 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2005 | 2017 |
| Metric | ATRC | ECVT |
|---|---|---|
| Price | $28.17 | $13.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $51.17 | $14.00 |
| AVG Volume (30 Days) | 769.9K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $201,630,000.00 | ★ $723,515,000.00 |
| Revenue This Year | $15.27 | $29.07 |
| Revenue Next Year | $12.21 | $6.71 |
| P/E Ratio | ★ N/A | $332.38 |
| Revenue Growth | ★ 15.40 | 2.70 |
| 52 Week Low | $25.52 | $7.35 |
| 52 Week High | $43.18 | $15.09 |
| Indicator | ATRC | ECVT |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 45.87 |
| Support Level | $26.47 | $12.74 |
| Resistance Level | $30.75 | $14.82 |
| Average True Range (ATR) | 1.36 | 0.48 |
| MACD | 0.20 | -0.16 |
| Stochastic Oscillator | 69.14 | 23.98 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.